Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value:
$740.06M
Total Bought:
$52.50M
Total Sold:
$317.43M
Net Transaction:
-$264.93M
Notable People:
Ting (Nmn) Jia, Octagon Capital Advisors, Llc
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Dianthus Therapeutics, Inc.(DNTH)1,841,6671,686,667-155,000$179.53M$148.51M20.07%-$31.01M
ABIVAX Société AnonymeADS(ABVX)993,000993,0000$132.33M$98.33M13.29%-$34.00M
Definium Therapeutics, Inc.(DFTX)2,950,0002,511,000-439,000$138.77M$95.57M12.91%-$43.20M
Cogent Biosciences, Inc.(COGT)2,350,0002,350,0000$90.94M$75.25M10.17%-$15.70M
ArriVent BioPharma, Inc.(AVBP)1,971,0542,141,387+170,333$68.47M$64.84M8.76%-$3.63M
Taysha Gene Therapies, Inc.(TSHA)9,693,2449,693,2440$66.01M$47.21M6.38%-$18.80M
Obsidian Therapeutics Inc02,414,610+2,414,610$0$33.15M4.48%+$33.15M
Kymera Therapeutics, Inc.(KYMR)310,000205,000-105,000$35.55M$22.92M3.10%-$12.63M
Disc Medicine, Inc.(IRON)270,000270,0000$19.75M$17.67M2.39%-$2.07M
Tango Therapeutics, Inc.(TNGX)0630,000+630,000$0$15.72M2.12%+$15.72M
Xenon Pharmaceuticals Inc.(XENE)490,000420,000-70,000$29.58M$15.62M2.11%-$13.96M
Adlai Nortye Group Ltd.ADS(ANL)934,716934,7160$10.75M$14.96M2.02%+$4.21M
Mirum Pharmaceuticals, Inc.(MIRM)338,900169,450-169,450$39.68M$14.48M1.96%-$25.19M
Aktis Oncology, Inc.(AKTS)960,847713,000-247,847$30.97M$13.88M1.88%-$17.09M
Palisade Bio, Inc.(PALI)10,276,31710,276,3170$21.48M$13.87M1.87%-$7.60M
BioAge Labs, Inc.(BIOA)1,748,0001,300,000-448,000$42.84M$9.22M1.25%-$33.63M
Pharvaris N V
COM
456,721249,000-207,721$15.79M$7.90M1.07%-$7.90M
Gyre Therapeutics, Inc.(GYRE)954,416954,4160$6.29M$7.00M0.95%+$706.3K
DBV Technologies S.A.ADS(DBVT)574,200574,2000$9.42M$6.75M0.91%-$2.66M
Ocular Therapeutix, Inc.(OCUL)2,075,000599,900-1,475,100$20.38M$4.60M0.62%-$15.78M
Trevi Therapeutics, Inc.(TRVI)315,000315,0000$5.87M$4.51M0.61%-$1.36M
Faeth Therapeutics, Inc.(FTH)361,010100,000-261,010$9.03M$2.97M0.40%-$6.05M
Precision BioSciences, Inc.(DTIL)1,350,000430,000-920,000$10.61M$2.69M0.36%-$7.92M
Unicycive Therapeutics, Inc.(UNCY)1,000,000275,000-725,000$4.69M$1.29M0.17%-$3.40M
Gossamer Bio, Inc.(GOSS)7,750,00096,875-7,653,125$1.28M$1.15M0.16%-$127.7K
Alumis Inc2,830,7000-2,830,700$79.66M$0—-$79.66M
Context Therapeutics Inc.(CNTX)3,050,0000-3,050,000$1.69M$0—-$1.69M
Summit Therapeutics Inc.(SMMT)1,250,0000-1,250,000$18.21M$0—-$18.21M
Page 1 of 1